Acanthamoeba Keratitis Successfully Treated Medically

Total Page:16

File Type:pdf, Size:1020Kb

Acanthamoeba Keratitis Successfully Treated Medically Br J Ophthalmol: first published as 10.1136/bjo.69.10.778 on 1 October 1985. Downloaded from British Journal of Ophthalmology, 1985, 69, 778-782 Acanthamoeba keratitis successfully treated medically PETER WRIGHT,' DAVID WARHURST,2 AND BARRIE R JONES' From 'Moorfields Eye Hospital, City Road, London, and the 2Amoebiasis Unit, Pathology Laboratory, Hospitalfor Tropical Diseases, London SUMMARY The first medical cure of a corneal infection due to an Acanthamoeba species is reported. The 44-year-old patient developed a suppurative keratitis associated with an epithelial defect, hypopyon, and secondary glaucoma. Acanthamoeba was confirmed as the causative agent four months after presentation when positive cultures were obtained from the cornea and from the conjunctiva. Sensitivity studies of the isolated organism were performed, and the infection was successfully controlled by treatment with a combination of dibromopropamidine and propamidine isethionate ointment and drops and neomycin drops. Keratoplasty was performed 22 months after onset, and no viable acanthamoebae were present in the resected tissue, though possible cyst remnants were identified by immunofluorescent techniques. copyright. Infection of the eye with Acanthamoeba species has tival cultures and smears showed no organisms and been reported many times'-7 and has been associated no growth in any media but only pus cells and debris. with a fatal meningoencephalitis.2 These infections A slow improvement in the signs followed subcon- are difficult to recognise and treat,' and acantha- junctival and topical gentamicin, mydriatics, and moeba is usually considered only after failure of topical dilute steroids with acetazolamide to control conventional treatment for more common causes of the intraocular pressure. The improvement was not suppurative keratitis. No medical cure has yet been maintained, and on several occasions the hypopyon http://bjo.bmj.com/ reported, and the outcome of all cases has been very increased for no obvious reason and then regressed poor, with excisional keratoplasty as the most again on continued treatment. This relapsing course successful diagnostic and therapeutic measure. continued for several months and in September the corneal epithelium broke down, with increasing Case report stromal suppuration and hypopyon, producing an appearance similar to that seen in a patient subse- CLINICAL PRESENTATION quently shown to have acanthamoeba infections. The patient was a 44-year-old meat porter, physically Smears continued to show only pus cells and debris on September 23, 2021 by guest. Protected very fit and a marathon runner. In April 1979 he was with no organisms. But special cultures for acantha- splashed in the right eye with blood from a condem- moeba from both cornea and conjunctiva grew ned carcass of meat but did not suffer any direct Acanthamoeba sp. identified morphologically as trauma to the eye. Within a few days the eye became A. polyphaga and continued to be positive for some red and sore and a variety of topical medicaments days (Table 1). Nasal and pharyngeal cultures for were given by the patient's general practitioner and acanthamoeba were also taken frequently and were local ophthalmologist including mydriatics, aureo- all negative, as were cultures from the unaffected mycin, gentamicin, and neomycin with corticosteroid left eye. drops. Because of continuing deterioration the patient was referred to Moorfields Eye Hospital, CULTURE TECHNIQUE where in June the findings were of a suppurative Petri dish plates were prepared with 1-5% Oxoid L28 keratitis, hypopyon, and secondary glaucoma with- agar, allowed to set, and left overnight at room out any distinctive features. Corneal and conjunc- temperature. Aerobacter (Klebsiella) aerogenes was Correspondence to Mr P Wright, FRCS, Moorfields Eye Hospital, grown in trypticase-soy broth or on nutrient agar, and City Road, London ECIV 2PD. the bacteria were washed by centrifugation three 778 Br J Ophthalmol: first published as 10.1136/bjo.69.10.778 on 1 October 1985. Downloaded from Acanthamoeba keratitis successfully treated medically 779 times in phosphate-buffered saline (PBS). The Table 1 Culture results bacterial pellet was resuspended to give a milky suspension in distilled water and stored (up to three Righteye months) at 4°C. Two to three drops were spread on Conjunctiva Cornea the agar plates, allowed to absorb at 37°C, and the patient's samples were inoculated directly on to the 17 Sept. + + 20 Sept. - + surface of the plates. They were incubated at 37°C in 24 Sept. - a moist atmosphere for up to three days, and were 27 Sept examined for growth of amoebae by an inverted 30 Sept. - + microscope. Further identification of the amoebae 4 Oct. - - 8 Oct. - _ was by examination of trophozoites and cysts in 13 Oct. - - suspension in Page's saline9 under normal light and 15 Oct. - - phase-contrast microscopy. On the basis of the 19 Oct. - presence of in the 23 Oct. acanthopodia slowly moving 28 Oct. trophozoite, and a polygonal double walled cyst with Nasal and nasopharyngeal cultures always negative characteristic ostioles, the organisms were assigned to the genus Acanthamoeba. clear at present and vision is 6/24, being reduced by TREATM ENT lens opacities. The intraocular pressure is controlled On the basis of previous sensitivity results from cases with timolol maleate 025% drops twice daily. of acanthamoeba infection at Moorfields (discussed Histological examination of the excised corneal later) treatment was begun with drops of propa- disc showed no special changes and no signs of midine isethionate 0 1% hourly by day and night with acanthamoeba on light or electron microscope dibromopropamidine ointment 0-15% four-hourly. examination. By immunofluorescent techniques After nine days of treatment the eye became much against acanthamoeba specific antigens it was pos- redder with rapidly worsening lid swelling despite sible to see small curved segments which took up the copyright. improvement in corneal signs. These changes were stain and which probably represented portions of attributed to toxicity, and since the sensitivity results broken up cyst wall. for the organism cultured (Table 2) were now available treatment was changed to neomycin drops SEROLOGY four-hourly day and night. By October the Serum was taken at the time of positive corneal and epithelium had healed, and four-hourly prednisolone conjunctival cultures and on four occasions during drops were added, with steady improvement in the the following month. A low level of antibody was corneal inflammatory signs. The treatment was present with a slight rise, but the titres were not http://bjo.bmj.com/ slowly reduced until the patient was using only significantly raised above levels found in 'normal' neomycin drops four times daily. These were con- sera (Table 3). Antibody could not be detected in tinued for one year, at which time limbal follicles serum or aqueous humour at the time of kerato- developed with some increased palpebral conjunc- plasty. tival hyperaemia and cellularity but no sign of any skin irritation. All topical therapy was stopped and Table 2 Relativesensitivities penetrating keratoplasty proposed, but not per- on September 23, 2021 by guest. Protected formed for a further four months at the patient's Minimalinhibitory concentrations request for social reasons. During this period all the (tg perml) limbal and conjunctival signs disappeared, and no topical therapy was given. IT AmC An 8 mm penetrating keratoplasty was carried out Myxin <12 2-4 22 months after initial presentation. The postopera- Paromomycin 4.9 4.9 tive treatment included propamidine isethionate Ziram 4-9 9-8 drops four times daily in addition to the usual topical Bayer 1703 >39-0 >39-0 Azalomycin 9-8 >19 5 steroid and antibiotics employed. The propamidine Venturicidin >312-0 >312-0 drops were continued four times daily for two months Neomycin sulphate 7-5 39-0 without any evidence of adverse effect on the corneal DS 9073 5-0 9-8 graft or the remainder of the eye. After cessation of Propamidine <125 <1*25 therapy the graft remained clear for nine months, Dibromopropamidinc <125 2-5 when a rejection episode developed but was easily IT= inhibition of trophozoite. controlled with topical steroids. The graft remains AmC=Amoebicidal (subculturc negativc). Br J Ophthalmol: first published as 10.1136/bjo.69.10.778 on 1 October 1985. Downloaded from 780 Peter Wright, David Warhurst, and Barrie R Jones Table 3 Serology against acanthamoeba (Ryan strain) typical acanthopodia. Where no apparently viable amoebae were found, the medium was centrifuged at 20 Scpt. 1/16 13 Oct. 1/32 700 g for five minutes, and the sediment was inocu- 27 Sept. 1/16 19 Oct. 1/32 4Oct. 1/16 lated on to non-nutrient agar plates coated with A. aerogenes and incubated further for 72 hours to detect any viable cysts or trophozoites. Each experiment therefore gave two results, a Discussion minimum inhibitory concentration (MIC) for inhibi- tion of trophozoite growth (MIC.I) and MIC for This case differs from others reported in that it was killing of trophozoites and cysts (MIC.AmC). Tests not associated with direct ocular trauma or previous were initially carried out on an isolate of acantha- corneal ulceration, acanthamoebae were recovered moeba from a corneal ulcer which was undergoing directly from the cornea and the conjunctival sac, and treatment at Moorfields Eye Hospital.' Subsequent the infection was subsequently controlled by topical less extensive tests with the most
Recommended publications
  • Confocal Microscopy in Cornea Guttata and Fuchs' Endothelial Dystrophy
    Br J Ophthalmol 1999;83:185–189 185 Confocal microscopy in cornea guttata and Fuchs’ Br J Ophthalmol: first published as 10.1136/bjo.83.2.185 on 1 February 1999. Downloaded from endothelial dystrophy Auguste G-Y Chiou, Stephen C Kaufman, Roger W Beuerman, Toshihiko Ohta, Hisham Soliman, Herbert E Kaufman Abstract conventional imaging methods.3–13 Because of Aims—To report the appearances of cor- its ability to focus the light source and the nea guttata and Fuchs’ endothelial dystro- image on the same focal plane, it allows real phy from white light confocal microscopy. time in vivo assessment of the diVerent layers Methods—Seven eyes of four consecutive of the cornea, including the endothelial layer. patients with cornea guttata were pro- Therefore, it may be an alternative method in spectively examined. Of the seven eyes, evaluating cornea guttata or Fuchs’ endothelial three also had corneal oedema (Fuchs’ dystrophy. dystrophy). In vivo white light tandem In the current study, we analysed the scanning confocal microscopy was per- appearances of cornea guttata and Fuchs’ dys- formed in all eyes. Results were compared trophy from confocal microscopy and compare with non-contact specular microscopy. the technique with non-contact specular mi- Results—Specular microscopy was pre- croscopy. cluded by corneal oedema in one eye. In the remaining six eyes, it demonstrated typical changes including pleomorphism, polymegathism, and the presence of gut- tae appearing as dark bodies, some with a central bright reflex. In all seven eyes, confocal microscopy revealed the pres- ence of round hyporeflective images with an occasional central highlight at the level of the endothelium.
    [Show full text]
  • Full Text in Pdf Format
    DISEASES OF AQUATIC ORGANISMS Published July 30 Dis Aquat Org Oral pharmacological treatments for parasitic diseases of rainbow trout Oncorhynchus mykiss. 11: Gyrodactylus sp. J. L. Tojo*, M. T. Santamarina Department of Microbiology and Parasitology, Laboratory of Parasitology, Faculty of Pharmacy, Universidad de Santiago de Compostela, E-15706 Santiago de Compostela, Spain ABSTRACT: A total of 24 drugs were evaluated as regards their efficacy for oral treatment of gyro- dactylosis in rainbow trout Oncorhj~nchusmykiss. In preliminary trials, all drugs were supplied to infected fish at 40 g per kg of feed for 10 d. Twenty-two of the drugs tested (aminosidine, amprolium, benznidazole, b~thionol,chloroquine, diethylcarbamazine, flubendazole, levamisole, mebendazole, n~etronidazole,mclosamide, nitroxynil, oxibendazole, parbendazole, piperazine, praziquantel, roni- dazole, secnidazole, tetramisole, thiophanate, toltrazuril and trichlorfon) were ineffective Triclabenda- zole and nitroscanate completely eliminated the infection. Triclabendazole was effective only at the screening dosage (40 g per kg of feed for 10 d), while nitroscanate was effective at dosages as low as 0.6 g per kg of feed for 1 d. KEY WORDS: Gyrodactylosis . Rainbow trout Treatment. Drugs INTRODUCTION to the hooks of the opisthohaptor or to ulceration as a result of feeding by the parasite. The latter is the most The monogenean genus Gyrodactylus is widespread, serious. though some individual species have a restricted distri- Transmission takes place largely as a result of direct bution. Gyrodactyloses affect numerous freshwater contact between live fishes, though other pathways species including salmonids, cyprinids and ornamen- (contact between a live fish and a dead fish, or with tal fishes, as well as marine fishes including gadids, free-living parasites present in the substrate, or with pleuronectids and gobiids.
    [Show full text]
  • Benznidazole(Rinn)
    830 Antiprotozoals Uses and Administration in endemic areas. It may also be used for prophylaxis in non- Neth.: Wellvone; Port.: Wellvone; S.Afr.: Wellvone; Spain: Wellvone; Atovaquone is a hydroxynaphthoquinone antiprotozo- immune travellers9,10 and appears to be well tolerated.10,11 Swed.: Wellvone; Switz.: Wellvone; UK: Wellvone; USA: Mepron. 1. Chiodini PL, et al. Evaluation of atovaquone in the treatment of Multi-ingredient: Austral.: Malarone; Austria: Malarone; Promal; Belg.: al that is also active against the fungus Pneumocystis patients with uncomplicated Plasmodium falciparum malaria. J Malarone; Canad.: Malarone; Cz.: Malarone; Denm.: Malarone; Fr.: Ma- jirovecii. It is used in the treatment and prophylaxis of Antimicrob Chemother 1995; 36; 1073–5. larone; Ger.: Malarone; Gr.: Malarone; Hong Kong: Malarone; Hung.: Ma- larone; Irl.: Malarone; Israel: Malarone; Ital.: Malarone; Malaysia: Malar- pneumocystis pneumonia in patients unable to tolerate 2. Looareesuwan S, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of one; Neth.: Malarone; Norw.: Malarone; NZ: Malarone; Pol.: Malarone; co-trimoxazole, and with proguanil in the treatment acute uncomplicated malaria in Thailand. Am J Trop Med Hyg S.Afr.: Malanil; Singapore: Malarone; Spain: Malarone; Swed.: Malarone; Switz.: Malarone; UK: Malarone; USA: Malarone. and prophylaxis of malaria. 1996; 54: 62–6. 3. Radloff PD, et al. Atovaquone and proguanil for Plasmodium In the treatment of mild to moderate pneumocystis falciparum malaria. Lancet 1996; 347: 1511–14. pneumonia, atovaquone is given orally in a dose of 4. Sabchareon A, et al. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Azanidazole (BAN, USAN, rINN) 750 mg with food twice daily as a suspension, for 21 Plasmodium falciparum malaria.
    [Show full text]
  • Antiseptics and Disinfectants for the Treatment Of
    Verstraelen et al. BMC Infectious Diseases 2012, 12:148 http://www.biomedcentral.com/1471-2334/12/148 RESEARCH ARTICLE Open Access Antiseptics and disinfectants for the treatment of bacterial vaginosis: A systematic review Hans Verstraelen1*, Rita Verhelst2, Kristien Roelens1 and Marleen Temmerman1,2 Abstract Background: The study objective was to assess the available data on efficacy and tolerability of antiseptics and disinfectants in treating bacterial vaginosis (BV). Methods: A systematic search was conducted by consulting PubMed (1966-2010), CINAHL (1982-2010), IPA (1970- 2010), and the Cochrane CENTRAL databases. Clinical trials were searched for by the generic names of all antiseptics and disinfectants listed in the Anatomical Therapeutic Chemical (ATC) Classification System under the code D08A. Clinical trials were considered eligible if the efficacy of antiseptics and disinfectants in the treatment of BV was assessed in comparison to placebo or standard antibiotic treatment with metronidazole or clindamycin and if diagnosis of BV relied on standard criteria such as Amsel’s and Nugent’s criteria. Results: A total of 262 articles were found, of which 15 reports on clinical trials were assessed. Of these, four randomised controlled trials (RCTs) were withheld from analysis. Reasons for exclusion were primarily the lack of standard criteria to diagnose BV or to assess cure, and control treatment not involving placebo or standard antibiotic treatment. Risk of bias for the included studies was assessed with the Cochrane Collaboration’s tool for assessing risk of bias. Three studies showed non-inferiority of chlorhexidine and polyhexamethylene biguanide compared to metronidazole or clindamycin. One RCT found that a single vaginal douche with hydrogen peroxide was slightly, though significantly less effective than a single oral dose of metronidazole.
    [Show full text]
  • Reseptregisteret 2013–2017 the Norwegian Prescription Database
    LEGEMIDDELSTATISTIKK 2018:2 Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Christian Berg Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Utgitt av Folkehelseinstituttet/Published by Norwegian Institute of Public Health Område for Helsedata og digitalisering Avdeling for Legemiddelstatistikk Juni 2018 Tittel/Title: Legemiddelstatistikk 2018:2 Reseptregisteret 2013–2017 / The Norwegian Prescription Database 2013–2017 Forfattere/Authors: Christian Berg, redaktør/editor Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Acknowledgement: Julie D. W. Johansen (English text) Bestilling/Order: Rapporten kan lastes ned som pdf på Folkehelseinstituttets nettsider: www.fhi.no The report can be downloaded from www.fhi.no Grafisk design omslag: Fete Typer Ombrekking: Houston911 Kontaktinformasjon/Contact information: Folkehelseinstituttet/Norwegian Institute of Public Health Postboks 222 Skøyen N-0213 Oslo Tel: +47 21 07 70 00 ISSN: 1890-9647 ISBN: 978-82-8082-926-9 Sitering/Citation: Berg, C (red), Reseptregisteret 2013–2017 [The Norwegian Prescription Database 2013–2017] Legemiddelstatistikk 2018:2, Oslo, Norge: Folkehelseinstituttet, 2018. Tidligere utgaver / Previous editions: 2008: Reseptregisteret 2004–2007 / The Norwegian Prescription Database 2004–2007 2009: Legemiddelstatistikk 2009:2: Reseptregisteret 2004–2008 / The Norwegian Prescription Database 2004–2008 2010: Legemiddelstatistikk 2010:2: Reseptregisteret 2005–2009. Tema: Vanedannende legemidler / The Norwegian Prescription Database 2005–2009.
    [Show full text]
  • Fusarium Keratitis and Corneal Collagen Cross
    FUSARIUM KERATITIS AND SURGERY REFRACTIVE CORNEAL COLLAGEN CROSS-LINKING BY MINAS CORONEO, AO, BSC(MED), MBBS, MSC SYD, MD, MS, UNSW, FRACS, FRANZCO; RAJESH FOGLA, DNB, FRCS(EDIN), MMED(OPHTH); WILLIAM B. TRATTLER, MD; ASHIYANA NARIANI, MD, MPH; COMPLEX CASE MANAGEMENT COMPLEX GARGI KHARE VORA, MD; AND ALAN N. CARLSON, MD CASE PRESENTATION A 42-year-old white man is referred to the Duke University Eye Center Cornea Service for a central corneal ulcer with a hypopyon in his right eye. The patient sustained the ocular injury while mowing the lawn, with debris getting into the eye while he was wearing contact lenses. He was diagnosed with culture-positive Fusarium species by the referring ophthalmologist and was treat- ed with oral voriconazole 200 mg twice daily and frequent topical natamycin 5% and voriconazole 10 mg/mL. The patient under- went epithelium-off corneal collagen cross-linking (CXL) approxi- Figure 1. Initial evaluation of the eye with a Fusarium corneal mately 4 weeks after diagnosis of the ulcer and was treated with infiltrate and hypopyon. a loteprednol steroid taper after the procedure. His condition subsequently progressed, with increasing eye pain, a nonhealing epithelial defect, and a worsening corneal infiltrate. Upon evaluation, the patient has a large corneal infiltrate with necrotic stroma, which is approaching the limbus, and a hypopyon (Figure 1). His UCVA measures 20/70-1. B-scan ultrasound of the right eye shows no evidence of posterior segment involvement. Reculturing of the corneal infiltrate is negative for bacteria, fungus, and Acanthamoeba. Confocal microscopy reveals no evidence of hyphae or cysts.
    [Show full text]
  • Simultaneous Determination of Some Antiprotozoal Drugs in Different
    Abdelaleem and Abdelwahab Chemistry Central Journal 2012, 6:27 http://journal.chemistrycentral.com/content/6/1/27 RESEARCHARTICLE Open Access Simultaneous determination of some antiprotozoal drugs in different combined dosage forms by mean centering of ratio spectra and multivariate calibration with model updating methods Eglal A Abdelaleem and Nada S Abdelwahab* Abstract Background: Metronidazole (MET) and Diloxanide Furoate (DF), act as antiprotozoal drugs, in their ternary mixtures with Mebeverine HCl (MEH), an effective antispasmodic drug. This work concerns with the development and validation of two simple, specific and cost effective methods mainly for simultaneous determination of the proposed ternary mixture. In addition, the developed multivariate calibration model has been updated to determine Metronidazole benzoate (METB) in its binary mixture with DF in Dimetrol® suspension. Results: Method (I) is the mean centering of ratio spectra spectrophotometric method (MCR) that depends on using the mean centered ratio spectra in two successive steps that eliminates the derivative steps and therefore the signal to noise ratio is enhanced. The developed MCR method has been successfully applied for determination of MET, DF and MEH in different laboratory prepared mixtures and in tablets. Method (II) is the partial least square (PLS) multivariate calibration method that has been optimized for determination of MET, DF and MEH in Dimetrol ® tablets and by updating the developed model, it has been successfully used for prediction of binary mixtures of DF and Metronidazole Benzoate ester (METB) in Dimetrol ® suspension with good accuracy and precision without reconstruction of the calibration set. Conclusion: The developed methods have been validated; accuracy, precision and specificity were found to be within the acceptable limits.
    [Show full text]
  • The Nitroimidazole Family of Drugs
    Br J Vener Dis: first published as 10.1136/sti.54.2.69 on 1 April 1978. Downloaded from British Journal of Venereal Diseases, 1978, 54, 69-71 Editorial The nitroimidazole family of drugs In 1955 an antibiotic complex isolated from a operative infection caused by susceptible anaerobes, strain of Streptomyces on the island of Reunion particularly in gynaecological surgery, appendi- was found by research workers of Rhone-Poulenc in cectomy, and colonic surgery. Paris to contain a trichomonacidal antibiotic- Real innovations in chemotherapy, such as azomycin. It had previously been isolated in Japan metronidazole, always attract attention from other (Maeda et al., 1953) and identified as 2-nitroimi- research groups. Although interest was slow to dazole (Ia see Table) (Nakamura, 1955). At the develop, research workers have sought analogous, time, and for some years after, this remarkably structurally-modified compounds which might afford simple compound defied synthesis, but it stimulated some advantage in clinical use-for example, the workers at Rhone-Poulenc to prepare and test greater potency, better tolerance and freedom from the activity of the more readily accessible isomeric side effects, a broader spectrum of action, a longer 5-nitroimidazoles (II). It was their good fortune in duration of action, or in some other characteristic. 1957 to find that these isomers were more active This effort has been concerned with important antiprotozoal agents than the natural product veterinary uses of 5-nitroimidazoles as well as the (Cosar and Julou, 1959). In a series of 150 related applications in human medicine. compounds, the one with a P-hydroxyethyl group Metronidazole has been a difficult target to in the 1-position gave the best compromise between improve upon, but several other drugs of this activity and toxicity and this brand of metroni- chemical family have been introduced to clinical dazole was introduced as Flagyl.
    [Show full text]
  • Reactive Uveitis, Retinal Vasculitis and Scleritis As Ocular End-Stage of Acanthamoeba Keratitis: a Histological Study
    Uveitis and vasculitis of Acanthamoeba keratitis ·Brief Report· Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study Lei Shi1,2, Tobias Hager1, Fabian Norbert Fries1, Loay Daas1, Leonard Holbach3, Carmen Hofmann- Rummelt3, Elena Zemova1, Berthold Seitz1, Nóra Szentmáry1,4 1Department of Ophthalmology, Saarland University Medical wearers. Its annual incidence was 17.53 to 21.14 per one Center, Homburg/Saar 66424, Germany million contact lens wearers in the UK[1]. In Germany, with 2Department of Ophthalmology, The First Affiliated Hospital about 80 million inhabitants, about 150 new cases have been of USTC, Division of Life Sciences and Medicine, University reported in a 10-year-period[2]. Studies showed that 68%-92.3% of Science and Technology of China, Hefei 230001, Anhui of AK patients are contact lens wearers[1,3-4]. Expression of Province, P.R. China mannosilated glycoproteins on corneal epithelial cell surface is 3Department of Ophthalmology, Friedrich-Alexander upregulated in contact lens wearers[3]. This plays an important University Erlangen-Nürnberg, Erlangen 91052, Germany role in AK pathogenesis. The Acanthamoeba trophozoite binds 4Department of Ophthalmology, Semmelweis University, to these proteins though its mannose-binding site in order to Budapest 1093, Hungary release the so-called mannose-induced protease 133 (MIP-133) Correspondence to: Lei Shi. Department of Ophthalmology, and Acanthamoeba plasminogen activator (aPA). MIP-133 and Saarland University Medical Center, Homburg/Saar, Kirrberger aPA give rise to lysis of epithelial, stromal cells and stromal Str. 100. 66424, Germany. [email protected] matrix, leading to corneal erosions and ulceration[4]. Presence Received: 2019-05-01 Accepted: 2019-08-21 of bacteria or fungi also supports Acanthamoeba growth, often resulting in co-infection[5].
    [Show full text]
  • Acanthamoeba, Fungal, and Bacterial Keratitis: a Comparison of Risk Factors and Clinical Features
    Acanthamoeba, Fungal, and Bacterial Keratitis: A Comparison of Risk Factors and Clinical Features JEENA MASCARENHAS, PRAJNA LALITHA, N. VENKATESH PRAJNA, MUTHIAH SRINIVASAN, MANORANJAN DAS, SEAN S. D’SILVA, CATHERINE E. OLDENBURG, DURGA S. BORKAR, ELIZABETH J. ESTERBERG, THOMAS M. LIETMAN, AND JEREMY D. KEENAN PURPOSE: To determine risk factors and clinical signs acanthamoeba keratitis research has been conducted in that may differentiate between bacterial, fungal, and industrialized countries, acanthamoeba keratitis also acanthamoeba keratitis among patients presenting with occurs in developing countries, often in non–contact presumed infectious keratitis. lens–wearing individuals.6,7 DESIGN: Hospital-based cross-sectional study. Acanthamoeba keratitis is frequently misdiagnosed as METHODS: We examined the medical records of 115 herpetic or fungal keratitis, and is subsequently treated incor- patients with laboratory-proven bacterial keratitis, 115 rectly, which can lead to poor outcomes.8 Case series of acan- patients with laboratory-proven fungal keratitis, and thamoeba keratitis have identified several important clinical 115 patients with laboratory-proven acanthamoeba kera- signs, such as pseudodendrites, perineural infiltrates, and ring titis seen at Aravind Eye Hospital, Madurai, India, from infiltrates.9,10 However, we are unaware of any studies that 2006-2011. Risk factors and clinical features of the 3 have compared the clinical findings of acanthamoeba organisms were compared using multinomial logistic keratitis with those of bacterial and fungal keratitis. regression. Clinical signs can be especially useful for differentiating the RESULTS: Of 95 patients with bacterial keratitis, 103 cause of infectious keratitis when microbiological testing is patients with fungal keratitis, and 93 patients with acan- not available—which is frequently the case in developing thamoeba keratitis who had medical records available for countries.
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • (RGP) Contact Lens Induced Microbial Keratitis in a Keratoconus Patient: a Case Report
    IOSR Journal of Dental and Medical Sciences (JDMS) ISSN: 2279-0853, ISBN: 2279-0861. Volume 1, Issue 5 (Sep-Oct. 2012), PP 12-16 www.iosrjournals.org Rigid Gas permeable (RGP) contact lens induced microbial keratitis in a keratoconus patient: A case report. Krishnendu Mandal. M.OPT1, Bhupesh Bagga. FRCS2, 3 Sobia Taureen. B. OPT 1,3 Optometry, L.V.Prasad Eye Institute, india 2Ophthalmology, L.V.Prasad Eye Institute, india ABSTRACT : Introduction: To report a case of microbial keratitis in an individual with keratoconus using rigid gas permeable contact lenses. Method: - A 23- year-old male presented with a history of pain, redness, photophobia, watering in right eye and his vision was reduced upon awakening. He was a known case of bilateral keratoconus who used rigid gas permeable contact lenses in both eyes on daily wear basis. Slitlamp examination revealed a paracentral stromal infiltrate in right eye. Corneal scrapings were collected for culture. Both contact lenses and lenses cleaning solution were collected for microbiological investigations. Result: - Corneal scraping revealed plenty gram-negative bacteria (Pseudomonas aeruginosa) and contact lenses cleaning solution revealed klebsiella. Conclusion:- Although microbial keratitis is an uncommon complication with rigid gas permeable contact lenses in keratoconus patients but it can be managed by proper microbiological work up and intensive medical care. Key words:KC-Keratoconus, RGP- rigid gas permeable contact lens, MK-Microbial keratitis, Pseudomonas aeruginosa, Klebsiella. I. Introduction
    [Show full text]